title: Communicating clinical research to reduce cancer risk through diet: Walnuts as a case example.
abstract: Inflammation is one mechanism through which cancer is initiated and progresses, and is implicated in the etiology of other conditions that affect cancer risk and prognosis, such as type 2 diabetes, cardiovascular disease, and visceral obesity. Emerging human evidence, primarily epidemiological, suggests that walnuts impact risk of these chronic diseases via inflammation. The published literature documents associations between walnut consumption and reduced risk of cancer, and mortality from cancer, diabetes, and cardiovascular disease, particularly within the context of the Mediterranean Diet. While encouraging, follow-up in human intervention trials is needed to better elucidate any potential cancer prevention effect of walnuts, per se. In humans, the far-reaching positive effects of a plant-based diet that includes walnuts may be the most critical message for the public. Indeed, appropriate translation of nutrition research is essential for facilitating healthful consumer dietary behavior. This paper will explore the translation and application of human evidence regarding connections with cancer and biomarkers of inflammation to the development of dietary guidance for the public and individualized dietary advice. Strategies for encouraging dietary patterns that may reduce cancer risk will be explored.
authors.affiliation: CDT Consulting, LLC, 464 Herndon Parkway, Suite 116, Herndon, VA 20171, USA.
authors.forename: Cheryl D
authors.initials: CD
authors.lastname: Toner
keywords: Cancer; communication; inflammation; prevention; walnuts
references.citation: Obesity (Silver Spring). 2010 Feb;18 Suppl 1:S102-4
references.pmid: 20107454
references.citation: J Am Coll Nutr. 2012 Dec;31(6):415-23
references.pmid: 23756586
references.citation: Circulation. 2004 Apr 6;109(13):1609-14
references.pmid: 15037535
references.citation: Endocrinol Metab Clin North Am. 2014 Mar;43(1):167-85
references.pmid: 24582097
references.citation: Nutr Cancer. 2011;63(6):960-70
references.pmid: 21774594
references.citation: J Nutr. 2004 Nov;134(11):2991-7
references.pmid: 15514264
references.citation: Diabetes Care. 2010 Feb;33(2):227-32
references.pmid: 19880586
references.citation: Nutrition. 2012 Jan;28(1):67-75
references.pmid: 21795022
references.citation: Am J Clin Nutr. 2012 Aug;96(2):296-301
references.pmid: 22760558
references.citation: J Obes. 2013;2013:291546
references.pmid: 24073332
references.citation: PLoS One. 2013;8(2):e57367
references.pmid: 23460844
references.citation: J Nutr. 2012 Jun;142(6):1019-25
references.pmid: 22535754
references.citation: CA Cancer J Clin. 2012 Jan-Feb;62(1):30-67
references.pmid: 22237782
references.citation: BMC Med. 2013 Jul 16;11:164
references.pmid: 23866098
references.citation: Nutr Cancer. 2014;66(1):14-28
references.pmid: 24279598
references.citation: J Nutr. 2014 Apr;144(4 Suppl):555S-560S
references.pmid: 24500939
references.citation: N Engl J Med. 2013 Nov 21;369(21):2001-11
references.pmid: 24256379
references.citation: J Nutr. 2013 Apr;143(4):512-8
references.pmid: 23427333
references.citation: Gerontologist. 2008 Jun;48(3):378-87
references.pmid: 18591363
references.citation: Food Chem Toxicol. 2010 Jan;48(1):441-7
references.pmid: 19883717
references.citation: N Engl J Med. 2018 Jun 21;378(25):2441-2442
references.pmid: 29897867
references.citation: Nutr J. 2008 May 02;7:13
references.pmid: 18454862
references.citation: Am J Clin Nutr. 2007 Feb;85(2):385-91
references.pmid: 17284733
references.citation: Am J Clin Nutr. 2009 Jul;90(1):56-63
references.pmid: 19458020
references.citation: Prostaglandins Leukot Essent Fatty Acids. 2012 Oct-Nov;87(4-5):111-7
references.pmid: 22959886
references.citation: J Am Coll Nutr. 2007 Aug;26(4):317-20
references.pmid: 17906182
references.citation: Nutr Cancer. 2008;60(5):666-74
references.pmid: 18791931
references.citation: Nutr Rev. 2012 May;70(5):301-10
references.pmid: 22537216
references.citation: Nat Rev Cancer. 2013 Nov;13(11):759-71
references.pmid: 24154716
references.citation: Atherosclerosis. 2007 Oct;194(2):e141-6
references.pmid: 17204269
references.citation: Cancer Epidemiol Biomarkers Prev. 2004 Oct;13(10):1595-603
references.pmid: 15466975
references.citation: CMAJ. 2013 Nov 5;185(16):E763-70
references.pmid: 24043651
references.citation: Br J Nutr. 2012 Nov 28;108(10):1764-72
references.pmid: 22244053
references.citation: Br J Cancer. 2013 Nov 26;109(11):2911-6
references.pmid: 24149179